The effect of probiotics on functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials

American Journal of Clinical Nutrition

Volumn 100, Issue 4, 2014, Pages 1075-1084

  Dimidi, Eirini ^a,b   Christodoulides, Stephanos ^a,b   Fragkos, Konstantinos C ^c   Scott, S Mark ^b   Whelan, Kevin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Digestive Diseases Research Centre   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT DISEASE; BIFIDOBACTERIUM ANIMALIS; CONSTIPATION; DEFECATION; DRUG EFFECT; FECES ANALYSIS; FUNCTIONAL CONSTIPATION; HUMAN; INTESTINE TRANSIT TIME; LACTOBACILLUS CASEI; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; PHYSIOLOGY;

CONSTIPATION; DEFECATION; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907258875     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.089151     Document Type: Review

References (64)

1. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and metaanalysis. Am J Gastroenterol 2011;106:1582-91.
2. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009;136:376-86.
3. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012;143(5):1179-87, e1-3.
4. Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm 2013;19:755-64.
5. Prescribing and Primary Care Services; Health and Social Care Information Centre. Prescriptions dispensed in the community. Leeds, United Kingdom: Health and Social Care Information Centre, 2013.
6. Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 2010;31:938-49.
7. Wald A, Scarpignato C, Kamm MA, Mueller-Lissner S, Helfrich I, Schuijt C, Bubeck J, Limoni C, Petrini O. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007;26:227-36.
8. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005;100(suppl 1):S1-4.
9. Basilisco G, Coletta M. Chronic constipation: a critical review. Dig Liver Dis 2013;45:886-93.
10. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007;25:599-608.
11. Müller-Lissner SA, Kaatz V, Brandt W, Keller J, Layer P. The perceived effect of various foods and beverages on stool consistency. Eur J Gastroenterol Hepatol 2005;17:109-12.
12. Food and Agriculture Organization of the United Nations and WHO Working Group. Guidelines for the evaluation of probiotics in food. Geneva, Switzerland: FAO/WHO, 2002.
13. Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J Gastroenterol 2010;16:69-75.
14. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005;37:838-49.
15. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 1998;87:836-41.
16. Ait-Belgnaoui A, Han W, Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 2006;55:1090-4.
17. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007;13:35-7.
18. Bueno L, de Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil 2007;19(suppl):89-119.
19. Quigley EM. Bacteria: a new player in gastrointestinal motility disorders- infections, bacterial overgrowth, and probiotics. Gastroenterol Clin North Am 2007;36:735-48.
20. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 2011;46:1057-64.
21. Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol Suppl 1997;222:45-8.
22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
23. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org (cited December 2013).
24. Moher D, Tricco AC. Issues related to the conduct of systematic reviews: a focus on the nutrition field. Am J Clin Nutr 2008;88:1191-9.
25. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA; Sage, 2001.
26. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002;31:140-9.
27. Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011;11:41.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
29. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006;11:193-206.
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-34.
31. Del Piano M, Carmagnola S, Anderloni A, Andorno S, Ballare M, Balzarini M, Montino F, Orsello M, Pagliarulo M, Sartori M, et al. The use of probiotics in healthy volunteers with evacuation disorders and hard stools a double-blind, randomized, placebo-controlled study. J Clin Gastroenterol 2010;44:S30-4.
32. Favretto DC, Pontin B, Moreira TR. Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis bi- 07) in improving symptoms of constipation. Arq Gastroenterol 2013; 50:196-201.
33. He M, Hu G, Yang Y. Effect of probiotic yogurt containing Bifidobacterium animalis strain DN-173 010 on symptoms of constipation. Chin J Gastroenterol 2009;14:287-9.
34. Ishizuka A, Tomizuka K, Aoki R, Nishijima T, Saito Y, Inoue R, Ushida K, Mawatari T, Ikeda T. Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans. J Biosci Bioeng 2012;113:587-91.
35. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003;17:655-9.
36. Krammer HJ, von Seggern H, Schaumburg J, Neumer F. Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation. Coloproctology 2011;33:109-13.
37. Mazlyn MM, Nagarajah LH, Fatimah A, Norimah AK, Goh KL. Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study. J Gastroenterol Hepatol 2013;28:1141-7.
38. Mollenbrink M, Bruckschen E. [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor).] Med Klin 1994;89:587-93 (in German).
39. Ojetti V, Ianiro G, Tortora A, Bruno G, Laterza L, Gigante G, Ponziani FR, Gammarita G, Gasbarrini A. Lactobacillus reuteri (DSM 17938) for the treatment of functional constipation in adult patients: a double-blind, randomised, placebo-controlled trial. Dig Liver Dis 2013;45:S132 (abstr).
40. Riezzo G, Orlando A, D'Attoma B, Guerra V, Valerio F, Lavermicocca P, De Candia S, Russo F. Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation-a double-blind, controlled, crossover study. Aliment Pharmacol Ther 2012;35:441-50.
41. Takii H, Nishijima T, Takami K, Tanaka Y, Inugami M, Mawatari T, Sugimura H, Aoki R. Effects of fermented milk containing Bifidobacterium animalis subsp. lactis GCL2505 on improvement of defecation, fecal properties, and intestinal microflora. Jpn Pharmacol Ther 2012;40:657-65.
42. Tilley L, Keppens K, Kushiro A, Takada T, Sakai T, Vaneechoutte M, Degeest B. A probiotic fermented milk drink containing Lactobacillus Casei strain Shirota improves stool consistency of subjects with hard stools. Int J Probiotics Prebiotics 2014;9:23-30.
43. Yang YX, He M, Hu G, Wei J, Pages P, Yang XH, Bourdu-Naturel S. Effect of a fermented milk containing Bifidobacterium lactis DN- 173010 on Chinese constipated women. World J Gastroenterol 2008; 14:6237-43.
44. Miller LE, Ouwehand AC. Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. World J Gastroenterol 2013;19:4718-25.
45. Kim ER, Rhee PL. How to interpret a functional or motility test- colon transit study. J Neurogastroenterol Motil 2012;18:94-9.
46. Southwell BR, Clarke MC, Sutcliffe J, Hutson JM. Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int 2009;25:559-72.
47. Kashyap PC, Marcobal A, Ursell LK, Larauche M, Duboc H, Earle KA, Sonnenburg ED, Ferreyra JA, Higginbottom SK, Million M, et al. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 2013;144:967-77.
48. Yajima T. Contractile effect of short-chain fatty acids on the isolated colon of the rat. J Physiol 1985;368:667-78.
49. Gorbatchef C, Jouet P, Coffin B, Flourie B, Lemann M, Franchisseur C, Jian R, Rambaud JC. Effects of short-chain fatty acids on the phasic and tonic motor activity in the unprepared colon of healthy humans. Gastroenterology 1998;114(4):A756.
50. Jouët P, Moussata D, Duboc H, Boschetti G, Attar A, Gorbatchef C, Sabate JM, Coffin B, Flourie B. Effect of short-chain fatty acids and acidification on the phasic and tonic motor activity of the human colon. Neurogastroenterol Motil 2013;25:943-9.
51. Connell AM, Hilton C, Irvine G, Lennard-Jones JE, Misiewicz JJ. Variation of bowel habit in two population samples. BMJ 1965;2:1095-9.
52. Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992;33:818-24.
53. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011;60:209-18.
54. Saad RJ, Rao SS, Koch KL, Kuo B, Parkman HP, McCallum RW, Sitrin MD, Wilding GE, Semler JR, Chey WD. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol 2010;105:403-11.
55. Emmanuel A, Quigley E, Simrén M, Feng Y, Müller-Lissner S, Urbain D, Tack J, Bredenoord A, Sabaté J, Yiannakou Y, et al. Factors affecting satisfaction with treatment in European women with chronic constipation: an Internet survey. United European Gastroenterol J 2013;1:375-84.
56. Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JNV, Suttorp MJ, Johnsen B, Shanman R, Slusser W, Fu N, et al. Safety of probiotics to reduce risk and prevent or treat disease. Evidence Report/Technology Assessment No. 200. (Prepared by the Southern California Evidencebased Practice Center under contract 290-2007-10062-I.) Rockville, MD: Agency for Healthcare Research and Quality, April 2011. (AHRQ publication 11-E007.) Available from: www.ahrq.gov/clinic/tp/probiotictp. htm (cited December 2013).
57. Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med 2009;169:1737-9.
58. Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 1997;32:1083-9.
59. Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 2013;145:749-57.
60. Wong RK, Palsson OS, Turner MJ, Levy RL, Feld AD, von Korff M, Whitehead WE. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 2010;105:2228-34.
61. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ; Design of Treatment Trials Committee. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-51.
62. Banaszkiewicz A, Szajewska H. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a doubleblind, placebo-controlled randomized trial. J Pediatr 2005;146:364-9.
63. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int 2007;49:485-90.
64. Vandenplas Y, Benninga M. Probiotics and functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr 2009;48(suppl 2):S107-9.